title: Inhibition of hydrogen sulfide generation contributes to lung injury after experimental orthotopic lung transplantation.
abstract: BACKGROUND
  Lung injury induced by ischemia or reperfusion significantly accounts for the risk of early mortality of lung transplantation (LT). Recent studies have demonstrated that hydrogen sulfide (H2S) and its endogenous synthase cystathionine-γ-lyase (CSE) confer protection against injury induced by ischemia or reperfusion in various organs. This prompted us to define the role of CSE/H2S pathway in transplantation-induced lung injury.
  
  
  METHODS
  We performed single left LT in male Sprague-Dawley rats after 3 h of cold ischemia time. H2S donor NaHS (14 μmol/kg, intraperitoneally) or CSE inhibitor propargylglycine (37.5 mg/kg, intraperitoneally) was administered 15 min before the start of the LT. CSE protein expression, H2S generation, and the severity of pulmonary graft injuries were estimated at 24 h after reperfusion.
  
  
  RESULTS
  Both CSE protein expression and H2S generation were markedly decreased in transplanted rat lungs compared with those in sham-operated lungs. In the lung-transplanted rats, NaHS administration significantly improved pulmonary function and decreased lipid peroxidation and myeloperoxidase activity. In addition, NaHS inhibited the production of interleukin 1β but increased interleukin 10 levels in graft lung tissues. In contrast, propargylglycine further exacerbated pulmonary function and lung injuries after experimental orthotopic LT.
  
  
  CONCLUSIONS
  To our knowledge, this study for the first time has demonstrated that the suppression of CSE expression and H2S production is associated with transplantation-induced lung injury. Both exogenous and endogenous H2S seem to have protective effects against acute LT injury by their multiple functions including antioxidation and anti-inflammation, suggesting that modulation of H2S levels may be considered a potential therapeutic approach in LT.
authors.affiliation: Department of Anesthesiology, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
authors.forename: Jingxiang
authors.initials: J
authors.lastname: Wu
authors.forename: Jionglin
authors.initials: J
authors.lastname: Wei
authors.forename: Xingji
authors.initials: X
authors.lastname: You
authors.forename: Xu
authors.initials: X
authors.lastname: Chen
authors.forename: Hongwei
authors.initials: H
authors.lastname: Zhu
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Zhu
authors.forename: Yujian
authors.initials: Y
authors.lastname: Liu
authors.forename: Meiying
authors.initials: M
authors.lastname: Xu
mesh_terms: D000480:Alkynes / Q000494:pharmacology; D000818:Animals; D050377:Cold Ischemia / Q000009:adverse effects*; D003542:Cystathionine gamma-Lyase / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005998:Glycine / Q000031:analogs & derivatives / Q000494:pharmacology; D006862:Hydrogen Sulfide / Q000037:antagonists & inhibitors* / Q000378:metabolism; D016753:Interleukin-10 / Q000378:metabolism; D053583:Interleukin-1beta / Q000378:metabolism; D015227:Lipid Peroxidation / Q000187:drug effects / Q000502:physiology; D055370:Lung Injury / Q000209:etiology* / Q000378:metabolism* / Q000503:physiopathology; D016040:Lung Transplantation; D008297:Male; D023421:Models, Animal; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000150:complications*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D013440:Sulfides / Q000494:pharmacology
chemical_list: D000480:Alkynes; D004791:Enzyme Inhibitors; D053583:Interleukin-1beta; D013440:Sulfides; D016753:Interleukin-10; C009055:propargylglycine; D003542:Cystathionine gamma-Lyase; C025451:sodium bisulfide; D005998:Glycine; D006862:Hydrogen Sulfide